Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSGeneric

ZEGALOGUE (AUTOINJECTOR)

DASIGLUCAGON HYDROCHLORIDE

Standard Dose
EQ 0.6MG BASE/0.6ML (EQ 0.6MG BASE/0.6ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ZEGALOGUE (AUTOINJECTOR) is listed in Drugs@FDA under application 214231 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DASIGLUCAGON HYDROCHLORIDE Form and strength SOLUTION;SUBCUTANEOUS - EQ 0.6MG BASE/0.6ML (EQ 0.6MG BASE/0.6ML) Sponsor ZEALAND PHARMA Submission history Latest submission status date: 2021-03-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZEGALOGUE (AUTOINJECTOR) is listed in Drugs@FDA under application 214231 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DASIGLUCAGON HYDROCHLORIDE Form and strength SOLUTION;SUBCUTANEOUS - EQ 0.6MG BASE/0.6ML (EQ 0.6MG BASE/0.6ML) Sponsor ZEALAND PHARMA Submission history Latest submission status date: 2021-03-22 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.